A detailed history of Legal & General Group PLC transactions in Alector, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 60,354 shares of ALEC stock, worth $266,161. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,354
Previous 58,861 2.54%
Holding current value
$266,161
Previous $354,000 2.54%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 01, 2024

BUY
$5.69 - $8.08 $8,495 - $12,063
1,493 Added 2.54%
60,354 $363,000
Q1 2024

May 14, 2024

SELL
$5.69 - $8.08 $4,443 - $6,310
-781 Reduced 1.31%
58,861 $354,000
Q4 2023

Feb 15, 2024

SELL
$3.77 - $8.39 $637 - $1,417
-169 Reduced 0.28%
59,642 $475,000
Q3 2023

Nov 14, 2023

BUY
$5.2 - $8.77 $28,646 - $48,313
5,509 Added 10.15%
59,811 $387,000
Q2 2023

Aug 14, 2023

SELL
$5.86 - $7.93 $8,930 - $12,085
-1,524 Reduced 2.73%
54,302 $326,000
Q1 2023

May 15, 2023

BUY
$5.85 - $9.84 $14,765 - $24,836
2,524 Added 4.74%
55,826 $345,000
Q4 2022

Feb 14, 2023

BUY
$6.88 - $9.55 $10,691 - $14,840
1,554 Added 3.0%
53,302 $491,000
Q3 2022

Nov 14, 2022

BUY
$8.19 - $13.2 $11,531 - $18,585
1,408 Added 2.8%
51,748 $490,000
Q2 2022

Aug 22, 2022

BUY
$7.65 - $14.24 $726 - $1,352
95 Added 0.19%
50,340 $512,000
Q1 2022

May 16, 2022

BUY
$13.02 - $20.78 $6,431 - $10,265
494 Added 0.99%
50,245 $716,000
Q4 2021

Feb 14, 2022

BUY
$19.35 - $25.54 $31,230 - $41,221
1,614 Added 3.35%
49,751 $1.03 Million
Q3 2021

Nov 15, 2021

BUY
$21.65 - $39.49 $58,779 - $107,215
2,715 Added 5.98%
48,137 $1.1 Million
Q2 2021

Aug 12, 2021

BUY
$15.5 - $22.48 $262,198 - $380,271
16,916 Added 59.34%
45,422 $947,000
Q1 2021

May 17, 2021

SELL
$14.84 - $22.23 $74 - $111
-5 Reduced 0.02%
28,506 $575,000
Q3 2020

Nov 13, 2020

BUY
$10.54 - $24.96 $160,850 - $380,914
15,261 Added 115.18%
28,511 $301,000
Q2 2020

Aug 14, 2020

BUY
$21.87 - $33.11 $167,524 - $253,622
7,660 Added 137.03%
13,250 $324,000
Q1 2020

May 14, 2020

SELL
$16.25 - $35.28 $10,643 - $23,108
-655 Reduced 10.49%
5,590 $134,000
Q4 2019

Feb 13, 2020

BUY
$14.17 - $20.3 $17,004 - $24,360
1,200 Added 23.79%
6,245 $108,000
Q3 2019

Nov 13, 2019

BUY
$14.42 - $22.2 $49,143 - $75,657
3,408 Added 208.19%
5,045 $73,000
Q2 2019

Aug 14, 2019

BUY
$16.26 - $26.42 $11,073 - $17,992
681 Added 71.23%
1,637 $31,000
Q1 2019

May 15, 2019

BUY
$15.97 - $22.5 $15,267 - $21,510
956 New
956 $18,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $364M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.